1、Life Sciences in India The Sector of TomorrowINDIAREAL ESTATECBRE RESEARCHMARCH 2023REPORTINTELLIGENT INVESTMENT2 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentContentsSnapshot of the Life Sciences(LS)Sector in IndiaLS Real Estate Clusters in IndiaFavo

2、urable Policy Ecosystem Fuelling the SectorAnnexuresGrowth Drivers for the LS Sector in IndiaLS Real Estate Trends in India142536Chapter 1 Snapshot of the Life Sciences(LS)Sector in India3 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentAs the world emer

3、ges out from the pandemic,new growth opportunities are unfolding in the LS sector globally with advancements in healthcare,technology and research.As India is one of the fastest growing LS markets of the world,we expect the sector to become a significant contributor to its economic growth over the c

4、oming years.The LS sector in India is further divided into three subsectors-pharmaceuticals,biotechnology and medical devices,each of which has played a prominent role in global/domestic markets in recent years(refer figure 1.1).Current Snapshot of the LS Sector in IndiaFigure 1.1:Key stats of India

5、n LS subsectorsSource:Invest India website updated as of 2022;2021-22 Annual Report of Ministry of Chemicals&Fertilizers,Government of India(GoI);CBRE Research,Q1 2023 Ranks 3rd globally in pharma production by volume Ranks 14th globally in pharma production by value USD 24.4 bn:Total pharma exports

6、 in 2020-21 USD 6.7 bn:Total pharma imports in 2020-21 Key segments in India include generic drugs,over-the-counter(OTC)medicines,bulk drugs,vaccines,contract research&manufacturing,biosimilars and biologicsPHARMACEUTICALS Among top 12 biotechnology destinations globally;3rd largest in Asia Pacific